Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03260504
Title Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications

clear cell renal cell carcinoma

renal cell carcinoma

Therapies

Aldesleukin + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.